SOPHARMA AD: Treasury shares

opublikowano: 2018-12-13 09:43

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_157_buy_back_12122018_espi.pdf  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 157 / 2018
Date of issue: 2018-12-13
Short name of the issuer
SOPHARMA AD
Subject
Treasury shares
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on December 12, 2018 the Company bought 3 000 own shares representing 0.0022% of the share capital of the Company, at a total value of 10 800.00 BGN on the Bulgarian Stock Exchange, the average price per share was 3.60 BGN.
The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from February 23, 2018.
The total number of treasury shares after this transaction is 8 858 336, representing 6.57% of the share capital of the Company.
Annexes
File Description
Current report 157 buy back 12122018 espi.pdfCurrent report 157 buy back 12122018 espi.pdf Treasury shares

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2018-12-13 Ognian Donev Executive director